Latest Articles

Publication Date
Endometrial Cancer and Mental Health: Challenges and Finding Support - Healthline

Endometrial Cancer and Mental Health: Challenges and Finding Support Healthline

Published: Feb. 3, 2025, 5:51 p.m.
Potential biomarkers and immune infiltration linking endometriosis with recurrent pregnancy loss based on bioinformatics and machine learning.

Endometriosis (EMs) is a chronic inflammatory disease characterized by the presence of endometrial tissue in the non-uterine cavity, resulting in dysmenorrhea, pelvic pain, and infertility. Epidemiologic data have suggested the …

Published: Feb. 3, 2025, midnight
(PDF) Radiotherapy improves stress urinary incontinence but impairs pelvic floor function in endometrial cancer patients: a prospective cohort study - ResearchGate

(PDF) Radiotherapy improves stress urinary incontinence but impairs pelvic floor function in endometrial cancer patients: a prospective cohort study ResearchGate

Published: Feb. 2, 2025, 4:08 a.m.
Retrospective Data Highlight FRα and B7-H4 As Potential ADC Targets in Endometrial Cancer - OncLive

Retrospective Data Highlight FRα and B7-H4 As Potential ADC Targets in Endometrial Cancer OncLive

Published: Feb. 1, 2025, 12:11 a.m.
Retrospective Data Highlight FRα and B7-H4 as Potential ADC Targets in Endometrial Cancer - OncLive

Retrospective Data Highlight FRα and B7-H4 as Potential ADC Targets in Endometrial Cancer OncLive

Published: Feb. 1, 2025, 12:11 a.m.
PPP2R1A Mutations Associated With Prolonged OS in High-Risk Endometrial Cancer - OncLive

PPP2R1A Mutations Associated With Prolonged OS in High-Risk Endometrial Cancer OncLive

Published: Jan. 31, 2025, 8:48 p.m.
New endometrial cancer study highlights overlooked risk factors - Brunel University News

New endometrial cancer study highlights overlooked risk factors Brunel University News

Published: Jan. 31, 2025, 3:25 p.m.
Molecular Subtyping Predicts Recurrence and Survival Benefits in Endometrial Cancer - OncLive

Molecular Subtyping Predicts Recurrence and Survival Benefits in Endometrial Cancer OncLive

Published: Jan. 30, 2025, 10:54 p.m.
Observational Data Challenge p53 Expression as a Surrogate Marker for TP53 Mutations in High-Risk Endometrial Cancer - OncLive

Observational Data Challenge p53 Expression as a Surrogate Marker for TP53 Mutations in High-Risk Endometrial Cancer OncLive

Published: Jan. 30, 2025, 10:29 p.m.
Endometrial Cancer Market Size to Reach USD 31.2 Billion by 2035, Impelled by Increasing Rates of Obesity and Hormonal Imbalances - BioSpace

Endometrial Cancer Market Size to Reach USD 31.2 Billion by 2035, Impelled by Increasing Rates of Obesity and Hormonal Imbalances BioSpace

Published: Jan. 30, 2025, 5:37 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!